C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2006
11/30/2006	CA2609202A1 Apoptosis promoters
11/30/2006	CA2608687A1 New antibiotic derivatives
11/30/2006	CA2608685A1 Substituted piperidines as renin inhibitors
11/29/2006	EP1726586A1 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1725551A1 Oxidized thioether derivatives of styryl-azoles and their use as her tyrosine kinases inhibitors
11/29/2006	EP1725550A2 Pyrrole-derivatives as factor xa inhibitors
11/29/2006	EP1725549A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
11/29/2006	EP1725543A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/29/2006	EP1725540A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
11/29/2006	EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP1725526A2 Method for preparing pyrrolidine oximes
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	EP1725239A1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
11/29/2006	EP1725235A1 Piperidine derivatives useful as ccr3 antagonists
11/29/2006	EP1725232A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
11/29/2006	EP1725102A1 Hiv integrase inhibitors
11/29/2006	EP1651642A4 Pna monomer and precursor
11/29/2006	EP1572207A4 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
11/29/2006	EP1553947A4 Quinazolinones and derivatives thereof as factor xa inhibitors
11/29/2006	EP1114028B1 Aza-bicycles which modulate the inhibition of cell adhesion
11/29/2006	CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006	CN1871222A Ccr3受体拮抗剂 Ccr3 receptor antagonists
11/29/2006	CN1871216A Inhibitors of cathepsin s
11/29/2006	CN1871029A Drug containing chymase inhibitor as the active ingredient
11/29/2006	CN1869029A Process for the asymmetric epoxidation of olefins
11/29/2006	CN1869027A Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/29/2006	CN1286823C Oxazolidine intermediate for preparing taxad alkane
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286817C Process for the preparation of benazepril hydrochloride
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286812C Bispiperidines as antithrombotic agents
11/29/2006	CN1286764C Non-heating clay composites for building materials
11/28/2006	US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/28/2006	US7141592 Substituted oxadiazolidinediones
11/28/2006	US7141588 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
11/28/2006	US7141583 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141570 antimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium
11/28/2006	US7141568 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/28/2006	US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006	US7141562 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents
11/28/2006	US7141533 optionally substituted thiazolyl, oxazolyl or pyrazolyl substituted heterocycles; use as pesticides and herbicides
11/28/2006	CA2378007C Benzimidazole compounds
11/28/2006	CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006125130A1 Methods for synthesizing heterocyclic compounds
11/23/2006	WO2006124816A1 Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use
11/23/2006	WO2006124780A2 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
11/23/2006	WO2006124447A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123249A2 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006122800A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
11/23/2006	WO2006122799A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
11/23/2006	WO2006122661A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	WO2006106437A3 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
11/23/2006	WO2006091862A3 Cytokine inhibitors and their use in therapy
11/23/2006	WO2006081034A3 Anti-inflammatory medicaments
11/23/2006	WO2006076802A8 An improved process for the preparation of mycophenolate mofetil
11/23/2006	WO2006069155A3 Inhibitors of protein arginine methyl transferases
11/23/2006	WO2006044732A3 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
11/23/2006	WO2006009907A3 Isoxazolidine compounds for treatment of bacterial infections
11/23/2006	WO2005112932A3 Raf modulators and methods of use
11/23/2006	WO2005054234A8 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/23/2006	US20060264643 One Pot Synthesis of 2-Oxazolidinone Derivatives
11/23/2006	US20060264631 Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264628 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
11/23/2006	US20060264627 Heterocyclic hydrazones as novel anti-cancer agents
11/23/2006	US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006	US20060264623 DNA-PK inhibitors
11/23/2006	US20060264589 copolymerizing butadiene and styrene in presence of a lithium initiating agent e.g.2-lithio-[4-(4-methylpiperazino)]phenyl-1,3-dithiane for performing living polymerization, terminating the addition copolymer with a terminating agent e.g. tributyltin chloride; molecular weight control
11/23/2006	US20060264496 Substituted indoline and indole derivatives
11/23/2006	US20060264487 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/23/2006	US20060264486 (5-{3-[4-(4,5,6,7-tetrahydro-benzooxazol-2-yl)-phenoxy]-propoxy}-indol-1-yl)-acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic disease
11/23/2006	US20060264450 Such as (S)-4-[(3-chloro-4-fluoro-phenyl)amino]-6-[2-(2-oxo-5-methyl-oxazolidin-3-yl)ethyloxy]-7-methoxy-quinazoline; inhibiting signal transduction by tyrosine kinases; treating tumoral diseases and benign prostatic hyperplasia, and diseases of lungs and respiratory tract
11/23/2006	US20060264440 Pyrazoles and methods of making and using the same
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264433 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264431 P38 inhibitors and methods of use thereof
11/23/2006	US20060264430 Pyrazole derivative
11/23/2006	US20060264429 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
11/23/2006	US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics
11/23/2006	US20060264425 Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
11/23/2006	US20060264419 Substituted pyrazoles
11/23/2006	US20060264415 Inhibitors of histone deacetylase
11/23/2006	US20060264385 like antiinfective (bactericide, fungicide, parasiticide, viricide), and antiproliferative, antiinflammatory, and prokinetic agents; 1,2,3-triazole-oxazolidine-phenyl- derivatives; effective against strains of cells or organisms that have developed drug resistance; administering orally
11/23/2006	US20060263928 Assembly of a semiconductor die attached to substrate with oxazoline derivative bearing an electron donor or acceptor functionality
11/23/2006	US20060261328 Blue light-emitting compounds, processes of preparing the same, and luminescent element including the same
11/23/2006	DE102005044814A1 New spiro-isoxazole-cycloalkane compounds, useful as vanilloid receptor 1 ligands for treating e.g. pain, depression and neurodegeneration
11/23/2006	CA2609288A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2608773A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
11/23/2006	CA2608419A1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	CA2608386A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
11/23/2006	CA2608324A1 Pyrolle derivatives as positive allosteric modulators of metabotropic glutamate receptors

1 ... 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 ... 647